{"id":"https://openalex.org/W2057586884","doi":"https://doi.org/10.1200/jco.2006.07.8956","title":"European Perspective on the Costs and Cost-Effectiveness of Cancer Therapies","display_name":"European Perspective on the Costs and Cost-Effectiveness of Cancer Therapies","publication_year":2007,"publication_date":"2007-01-08","ids":{"openalex":"https://openalex.org/W2057586884","doi":"https://doi.org/10.1200/jco.2006.07.8956","mag":"2057586884","pmid":"https://pubmed.ncbi.nlm.nih.gov/17210939"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.07.8956","doi":"https://doi.org/10.1200/jco.2006.07.8956","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.07.8956","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048106372","display_name":"Michael Drummond","orcid":"https://orcid.org/0000-0002-6126-0944","observed_orcids":["https://orcid.org/0000-0002-6126-0944","https://orcid.org/0000-0002-4941-9107"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael F. Drummond","raw_affiliation_strings":["From the Centre for Health Economics, University of York, York, United Kingdom","Centre for Health Economics, University of York, York, United Kingdom. md18@york.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Centre for Health Economics, University of York, York, United Kingdom","institution_ids":["https://openalex.org/I52099693"]},{"raw_affiliation_string":"Centre for Health Economics, University of York, York, United Kingdom. md18@york.ac.uk","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081568693","display_name":"Anne Mason","orcid":"https://orcid.org/0000-0002-5823-3064","observed_orcids":["https://orcid.org/0000-0002-5823-3064"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anne R. Mason","raw_affiliation_strings":["From the Centre for Health Economics, University of York, York, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Centre for Health Economics, University of York, York, United Kingdom","institution_ids":["https://openalex.org/I52099693"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I52099693"],"apc_list":null,"apc_paid":null,"fwci":29.2055,"has_fulltext":false,"cited_by_count":119,"citation_normalized_percentile":{"value":0.99542162,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":100},"biblio":{"volume":"25","issue":"2","first_page":"191","last_page":"195"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7085000276565552,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7085000276565552,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.1818999946117401,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.1080000028014183,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9700000286102295},{"id":"https://openalex.org/keywords/third-party-payers","display_name":"third-party payers","score":0.8019999861717224},{"id":"https://openalex.org/keywords/reference-pricing","display_name":"reference pricing","score":0.777999997138977},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.5849999785423279},{"id":"https://openalex.org/keywords/hospital-formulary","display_name":"hospital formulary","score":0.8600000143051147},{"id":"https://openalex.org/keywords/access-to-cancer-drugs","display_name":"access to cancer drugs","score":0.9660000205039978},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.6930000185966492},{"id":"https://openalex.org/keywords/nice","display_name":"Nice","score":0.4569999873638153},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.48100000619888306},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.5130000114440918},{"id":"https://openalex.org/keywords/european-health-policy","display_name":"European health policy","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C100406419","wikidata":"https://www.wikidata.org/wiki/Q3543802","display_name":"Formulary","level":2,"score":0.8415956497192383},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.7694576978683472},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7121933102607727},{"id":"https://openalex.org/C2776650110","wikidata":"https://www.wikidata.org/wiki/Q12891156","display_name":"Seriousness","level":2,"score":0.5710656642913818},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.5303657054901123},{"id":"https://openalex.org/C2778137410","wikidata":"https://www.wikidata.org/wiki/Q2732820","display_name":"Government (linguistics)","level":2,"score":0.4525354504585266},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.42135557532310486},{"id":"https://openalex.org/C2777352838","wikidata":"https://www.wikidata.org/wiki/Q5419420","display_name":"Excellence","level":2,"score":0.41985005140304565},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4111780524253845},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.398319810628891},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.3743416368961334},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3188377618789673},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.25737154483795166},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.2196601927280426},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.18406078219413757},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.12948951125144958},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.12617382407188416},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.1191568374633789},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003363","descriptor_name":"Cost Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007349","descriptor_name":"Insurance, Health, Reimbursement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008495","descriptor_name":"Medical Oncology","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2006.07.8956","doi":"https://doi.org/10.1200/jco.2006.07.8956","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.07.8956","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:17210939","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17210939","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.766700029373169,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W2065257072","https://openalex.org/W2085671383","https://openalex.org/W2095095509","https://openalex.org/W2129573808","https://openalex.org/W2140519673"],"related_works":["https://openalex.org/W2026383666","https://openalex.org/W1974551630","https://openalex.org/W2075268203","https://openalex.org/W2539547660","https://openalex.org/W4400274333","https://openalex.org/W4250578354","https://openalex.org/W2262514417","https://openalex.org/W2802339919","https://openalex.org/W2543700152","https://openalex.org/W2901613372"],"abstract_inverted_index":{"In":[0],"Europe,":[1],"the":[2,6,16,22,67,73,90,96,99,106,132,136,159,170,179,200,203,207,217,235,252],"vast":[3],"majority":[4],"of":[5,8,25,54,63,75,138,161,166,199,202,209,219,247],"costs":[7],"cancer":[9,103,121,184,214],"therapy":[10],"fall":[11],"on":[12],"third-party":[13],"payers,":[14],"normally":[15],"government,":[17],"or":[18,82,93],"sickness":[19],"funds.":[20],"Therefore,":[21],"main":[23,52,100],"focus":[24],"cost-effectiveness":[26,221],"studies":[27,240],"is":[28,57,105,238],"to":[29,78,83,120,250],"assist":[30],"payers":[31],"in":[32,47,89,118,129,141,149,155,178],"deciding":[33],"whether":[34],"new":[35,162],"therapies":[36,211],"are":[37,45],"worthwhile,":[38],"despite":[39],"their":[40],"high":[41],"cost.":[42],"Drug":[43],"budgets":[44],"regulated":[46],"most":[48,68,191],"European":[49,116],"countries.":[50],"The":[51],"form":[53,62],"central":[55],"control":[56,101],"price":[58,74,86],"setting,":[59],"with":[60,190],"some":[61,213],"reference":[64],"pricing":[65,224],"being":[66,193],"common":[69,85],"approach.":[70],"This":[71,195],"sets":[72],"drugs,":[76],"either":[77],"an":[79],"international":[80],"standard,":[81],"a":[84,112,231],"for":[87,124,173,212,223,234],"drugs":[88,104,185],"same":[91],"group":[92],"cluster.":[94],"At":[95],"hospital":[97,107],"level,":[98],"over":[102],"formulary.":[108],"Studies":[109],"have":[110,186],"shown":[111],"wide":[113],"variation":[114],"among":[115],"countries":[117,148],"access":[119],"drugs.":[122,163],"Explanations":[123],"these":[125],"variations":[126],"include":[127],"differences":[128],"research":[130],"funding,":[131],"drug":[133],"approval":[134],"process,":[135],"role":[137],"health":[139,204],"economics":[140],"decision":[142],"making,":[143],"and":[144,175,206,225],"budgetary":[145],"issues.":[146],"Several":[147],"Europe":[150],"now":[151],"require":[152],"economic":[153],"data":[154],"making":[156],"decisions":[157,167,227],"about":[158],"reimbursement":[160,226],"An":[164],"examination":[165],"made":[168],"by":[169],"National":[171],"Institute":[172],"Health":[174],"Clinical":[176],"Excellence":[177],"United":[180],"Kingdom":[181],"suggests":[182],"that":[183,239],"fared":[187],"quite":[188],"well,":[189],"recommendations":[192],"positive.":[194],"could":[196],"be":[197,242],"because":[198],"seriousness":[201],"condition":[205],"lack":[208],"alternative":[210],"patients.":[215],"If":[216],"policy":[218],"requesting":[220],"evidence":[222],"becomes":[228],"more":[229],"popular,":[230],"major":[232],"implication":[233],"pharmaceutical":[236],"industry":[237],"should":[241],"conducted":[243],"during":[244],"phase":[245],"III":[246],"clinical":[248],"development":[249],"generate":[251],"required":[253],"data.":[254]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":9}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}